SAPONARO, FEDERICA Statistiche
SAPONARO, FEDERICA
DIPARTIMENTO DI PATOLOGIA CHIRURGICA, MEDICA, MOLECOLARE E DELL'AREA CRITICA
3-iodothyronamine (T1AM) is taken up and rapidly metabolized in neuronal cells
2019-01-01 Saponaro, Federica; Borsò, Marco; Verlotta, Sara; Bandini, Lavinia; Saba, Alessandro; Zucchi, Riccardo; Ghelardoni, Sandra
A Novel Mutation in the Calcium Sensing Receptor Gene in an Italian Family Affected by Autosomal Dominant Hypocalcemia
2018-01-01 Cetani, F; Borsari, S; Saponaro, F; Pardi, E; Banti, C; Mazoni, L; Apicella, M; Marcocci, C
A Prospective Study on Juvenile Primary Hyperparathyroidism Population.
2014-01-01 Saponaro, F; Cacciato, F; Pardi, E; Borsari, S; Marcocci, C; Cetani, F
A proteomic approach to study parathyroid glands
2011-01-01 Giusti, Laura; Cetani, F; Ciregia, Federica; DA VALLE, Ylenia; Donadio, Elena; Giannaccini, Gino; Banti, C; Pardi, E; Saponaro, F; Basolo, Fulvio; Berti, P; Miccoli, Paolo; Pinchera, A; Marcocci, Claudio; Lucacchini, Antonio
ACE2 in the era of SARS-CoV-2: controversies and novel perspectives
2020-01-01 Saponaro, Federica; Rutigliano, Grazia; Sestito, Simona; Bandini, Lavinia; Storti, Barbara; Bizzarri, Ranieri; Zucchi, Riccardo
An update on vitamin d metabolism
2020-01-01 Saponaro, F.; Saba, A.; Zucchi, R.
Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
2013-01-01 Pardi, E; Marcocci, Claudio; Borsari, S; Saponaro, F; Torregrossa, L; Tancredi, M; Raspini, B; Basolo, Fulvio; Cetani, F.
Assay of endogenous 3,5-diiodo-L-thyronine (3,5-T2) and 3,3’-diiodo-L-thyronine (3,3’-T2) in human serum: a feasibility study
2019-01-01 Lorenzini, Leonardo; Nguyen, Nhat Minh; Sacripanti, Ginevra; Serni, Enrico; Borso', Marco; Saponaro, Federica; Cecchi, Elena; Simoncini, Tommaso; Ghelardoni, Sandra; Zucchi, Riccardo; Saba, Alessandro
Beta-catenin activation is not involved in sporadic parathyroid carcinomas and adenomas
2010-01-01 Cetani, F; Pardi, E; Banti, C; Collecchi, P; Viacava, P; Borsari, S; Fanelli, G; Naccarato, Ag; Saponaro, F; Berti, P; Miccoli, P; Pinchera, A; Marcocci, C
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer.
2013-01-01 Cetani, F; Banti, C; Pardi, E; Borsari, S; Viacava, P; Miccoli, P; Torregrossa, L; Basolo, F; Pelizzo, Mr; Rugge, M; Pennelli, G; Gasparri, G; Papotti, M; Volante, M; Vignali, E; Saponaro, F; Marcocci, C
CDC73/HRPT2 mutations and parafibromin immunohistochemistry in a large series of sporadic parathyroid carcinomas and atypical adenomas
2013-01-01 Cetani, F; Banti, C; Pardi, E; Torregrossa, L; Borsari, S; Saponaro, F; Rugge, M; Pennelli, G; Pelizzo, M; Papotti, M; Volante, M; Gasparri, G; Miccoli, P; Marcocci, C
Cinacalcet efficacy in patients with moderately severe primary hyperparathyroidism according to the European Medicine Agency prescription labeling.
2012-01-01 Cetani, F; Saponaro, F; Banti, C; Cianferotti, L; Vignali, E; Chiavistelli, S; Viccica, G; Pinchera, A; Marcocci, Claudio
Cinacalcet in the management of primary hyperparathyroidism: Post marketing experience of an Italian multicentre group
2013-01-01 Saponaro, Federica; Faggiano, Antongiulio; Grimaldi, Franco; Borretta, Giorgio; Brandi, Maria Luisa; Minisola, Salvatore; Frasoldati, Andrea; Papini, Enrico; Scillitani, Alfredo; Banti, Chiara; Prete, Michela Del; Vescini, Fabio; Gianotti, Laura; Cavalli, Loredana; Romagnoli, Elisabetta; Colao, Annamaria; Cetani, Filomena; Marcocci, Claudio
CLINICAL PRESENTATION AND MANAGEMENT OF PATIENTS WITH PRIMARY HYPERPARATHYROIDISM IN ITALY
2018-01-01 Saponaro, F.; Cetani, F.; Repaci, A.; Pagotto, U.; Cipriani, C.; Pepe, J.; Minisola, S.; Cipri, C.; Vescini, F.; Scillitani, A.; Salcuni, A.; Palmieri, S.; Eller-Vainiche, r. C.; Chiodini, Davide; I, Madeo; B, Kara; E, Castellano; E, ; Gianotti, L; Borretta, G; Romanelli, ; F., Camozzi; V, Faggiano; A, ; Corbetta, S; Cianferotti, L; De Feo, Ml; Palermo, ; A, Vezzoli; G, Maino; F, Scalese; M, ; Marcocci, C
Clinical presentation and management of patients with primary hyperparathyroidism in Italy
2018-01-01 Saponaro, F; Cetani, F; Repaci, A; Pagotto, U; Cipriani, C; Pepe, J; Minisola, S; Cipri, C; Vescini, F; Scillitani, A; Salcuni, A; Palmieri, S; Eller-Vainicher, C; Chiodini, I; Madeo, B; Kara, E; Castellano, E; Borretta, G; Gianotti, L; Romanelli, F; Camozzi, V; Faggiano, A; Corbetta, S; Cianferotti, L; Brandi, M L; De Feo, M L; Palermo, A; Vezzoli, G; Maino, F; Scalese, M; Marcocci, C
Clinical presentation and management of primary hyperparathyroidism in Italy
2017-01-01 Saponaro, F; Cetani, F; Repaci, A; Camozzi, V; Minisola, S; Scillitani, A; Chiodini, I; Romanelli, F; Madeo, B; Gianotti, L; Faggiano, A; Cianferotti, L; Corbetta, S; De Feo, Ml; Palermo, A; Pozzilli, P; Marcocci, C
Clinical profile of juvenile primary hyperparathyroidism: a prospective study
2018-01-01 Saponaro, Federica; Marcocci, Claudio; Cacciatore, Federica; Miccoli, Mario; Pardi, Elena; Borsari, Simona; Materazzi, Gabriele; Miccoli, Paolo; Cetani, Filomena
Come definire lo status della vitamina 25OHD: aspetti metodologici (laboratorio) e clinici (VDBP, free 25OHD, bioavailable 25(OH)D)
2019-01-01 Saponaro, Federica; Marcocci, Claudio
Correction to: Whole exome sequencing in familial isolated primary hyperparathyroidism
2020-01-01 Cetani, F; Pardi, E; Aretini, P; Saponaro, F; Borsari, S; Mazoni, L; Apicella, M; Civita, P; La Ferla, M; Caligo, M A; Lessi, F; Mazzanti, C M; Torregrossa, L; Oppo, A; Marcocci, C
Development of an algorithm to predict serum vitamin D levels using a simple questionnaire based on sunlight exposure
2017-01-01 Vignali, Edda; Macchia, Enrico; Cetani, Filomena; Reggiardo, Giorgio; Cianferotti, Luisella; Saponaro, Federica; Marcocci, Claudio
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
3-iodothyronamine (T1AM) is taken up and rapidly metabolized in neuronal cells | 1-gen-2019 | Saponaro, Federica; Borsò, Marco; Verlotta, Sara; Bandini, Lavinia; Saba, Alessandro; Zucchi, Riccardo; Ghelardoni, Sandra | |
A Novel Mutation in the Calcium Sensing Receptor Gene in an Italian Family Affected by Autosomal Dominant Hypocalcemia | 1-gen-2018 | Cetani, F; Borsari, S; Saponaro, F; Pardi, E; Banti, C; Mazoni, L; Apicella, M; Marcocci, C | |
A Prospective Study on Juvenile Primary Hyperparathyroidism Population. | 1-gen-2014 | Saponaro, F; Cacciato, F; Pardi, E; Borsari, S; Marcocci, C; Cetani, F | |
A proteomic approach to study parathyroid glands | 1-gen-2011 | Giusti, Laura; Cetani, F; Ciregia, Federica; DA VALLE, Ylenia; Donadio, Elena; Giannaccini, Gino; Banti, C; Pardi, E; Saponaro, F; Basolo, Fulvio; Berti, P; Miccoli, Paolo; Pinchera, A; Marcocci, Claudio; Lucacchini, Antonio | |
ACE2 in the era of SARS-CoV-2: controversies and novel perspectives | 1-gen-2020 | Saponaro, Federica; Rutigliano, Grazia; Sestito, Simona; Bandini, Lavinia; Storti, Barbara; Bizzarri, Ranieri; Zucchi, Riccardo | |
An update on vitamin d metabolism | 1-gen-2020 | Saponaro, F.; Saba, A.; Zucchi, R. | |
Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas. | 1-gen-2013 | Pardi, E; Marcocci, Claudio; Borsari, S; Saponaro, F; Torregrossa, L; Tancredi, M; Raspini, B; Basolo, Fulvio; Cetani, F. | |
Assay of endogenous 3,5-diiodo-L-thyronine (3,5-T2) and 3,3’-diiodo-L-thyronine (3,3’-T2) in human serum: a feasibility study | 1-gen-2019 | Lorenzini, Leonardo; Nguyen, Nhat Minh; Sacripanti, Ginevra; Serni, Enrico; Borso', Marco; Saponaro, Federica; Cecchi, Elena; Simoncini, Tommaso; Ghelardoni, Sandra; Zucchi, Riccardo; Saba, Alessandro | |
Beta-catenin activation is not involved in sporadic parathyroid carcinomas and adenomas | 1-gen-2010 | Cetani, F; Pardi, E; Banti, C; Collecchi, P; Viacava, P; Borsari, S; Fanelli, G; Naccarato, Ag; Saponaro, F; Berti, P; Miccoli, P; Pinchera, A; Marcocci, C | |
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer. | 1-gen-2013 | Cetani, F; Banti, C; Pardi, E; Borsari, S; Viacava, P; Miccoli, P; Torregrossa, L; Basolo, F; Pelizzo, Mr; Rugge, M; Pennelli, G; Gasparri, G; Papotti, M; Volante, M; Vignali, E; Saponaro, F; Marcocci, C | |
CDC73/HRPT2 mutations and parafibromin immunohistochemistry in a large series of sporadic parathyroid carcinomas and atypical adenomas | 1-gen-2013 | Cetani, F; Banti, C; Pardi, E; Torregrossa, L; Borsari, S; Saponaro, F; Rugge, M; Pennelli, G; Pelizzo, M; Papotti, M; Volante, M; Gasparri, G; Miccoli, P; Marcocci, C | |
Cinacalcet efficacy in patients with moderately severe primary hyperparathyroidism according to the European Medicine Agency prescription labeling. | 1-gen-2012 | Cetani, F; Saponaro, F; Banti, C; Cianferotti, L; Vignali, E; Chiavistelli, S; Viccica, G; Pinchera, A; Marcocci, Claudio | |
Cinacalcet in the management of primary hyperparathyroidism: Post marketing experience of an Italian multicentre group | 1-gen-2013 | Saponaro, Federica; Faggiano, Antongiulio; Grimaldi, Franco; Borretta, Giorgio; Brandi, Maria Luisa; Minisola, Salvatore; Frasoldati, Andrea; Papini, Enrico; Scillitani, Alfredo; Banti, Chiara; Prete, Michela Del; Vescini, Fabio; Gianotti, Laura; Cavalli, Loredana; Romagnoli, Elisabetta; Colao, Annamaria; Cetani, Filomena; Marcocci, Claudio | |
CLINICAL PRESENTATION AND MANAGEMENT OF PATIENTS WITH PRIMARY HYPERPARATHYROIDISM IN ITALY | 1-gen-2018 | Saponaro, F.; Cetani, F.; Repaci, A.; Pagotto, U.; Cipriani, C.; Pepe, J.; Minisola, S.; Cipri, C.; Vescini, F.; Scillitani, A.; Salcuni, A.; Palmieri, S.; Eller-Vainiche, r. C.; Chiodini, Davide; I, Madeo; B, Kara; E, Castellano; E, ; Gianotti, L; Borretta, G; Romanelli, ; F., Camozzi; V, Faggiano; A, ; Corbetta, S; Cianferotti, L; De Feo, Ml; Palermo, ; A, Vezzoli; G, Maino; F, Scalese; M, ; Marcocci, C | |
Clinical presentation and management of patients with primary hyperparathyroidism in Italy | 1-gen-2018 | Saponaro, F; Cetani, F; Repaci, A; Pagotto, U; Cipriani, C; Pepe, J; Minisola, S; Cipri, C; Vescini, F; Scillitani, A; Salcuni, A; Palmieri, S; Eller-Vainicher, C; Chiodini, I; Madeo, B; Kara, E; Castellano, E; Borretta, G; Gianotti, L; Romanelli, F; Camozzi, V; Faggiano, A; Corbetta, S; Cianferotti, L; Brandi, M L; De Feo, M L; Palermo, A; Vezzoli, G; Maino, F; Scalese, M; Marcocci, C | |
Clinical presentation and management of primary hyperparathyroidism in Italy | 1-gen-2017 | Saponaro, F; Cetani, F; Repaci, A; Camozzi, V; Minisola, S; Scillitani, A; Chiodini, I; Romanelli, F; Madeo, B; Gianotti, L; Faggiano, A; Cianferotti, L; Corbetta, S; De Feo, Ml; Palermo, A; Pozzilli, P; Marcocci, C | |
Clinical profile of juvenile primary hyperparathyroidism: a prospective study | 1-gen-2018 | Saponaro, Federica; Marcocci, Claudio; Cacciatore, Federica; Miccoli, Mario; Pardi, Elena; Borsari, Simona; Materazzi, Gabriele; Miccoli, Paolo; Cetani, Filomena | |
Come definire lo status della vitamina 25OHD: aspetti metodologici (laboratorio) e clinici (VDBP, free 25OHD, bioavailable 25(OH)D) | 1-gen-2019 | Saponaro, Federica; Marcocci, Claudio | |
Correction to: Whole exome sequencing in familial isolated primary hyperparathyroidism | 1-gen-2020 | Cetani, F; Pardi, E; Aretini, P; Saponaro, F; Borsari, S; Mazoni, L; Apicella, M; Civita, P; La Ferla, M; Caligo, M A; Lessi, F; Mazzanti, C M; Torregrossa, L; Oppo, A; Marcocci, C | |
Development of an algorithm to predict serum vitamin D levels using a simple questionnaire based on sunlight exposure | 1-gen-2017 | Vignali, Edda; Macchia, Enrico; Cetani, Filomena; Reggiardo, Giorgio; Cianferotti, Luisella; Saponaro, Federica; Marcocci, Claudio |